[1] HELFENSTEIN A,VAHERMO M,NAWROT D A,et al. Antibacterial profiling of abietane-type diterpenoids[J]. Bioorganic & Medicinal Chemistry,2017,25(1):132-137. [2] VAFINA G F,UZBEKOV A R,ZARUBAEV V V,et al. Search for antiviral agents among quinopimaric acid scaffold derivatives[J]. Chemistry of Natural Compounds,2015,51(1):103-107. [3] TRETYAKOVA E V,SMIRNOVA I E,KAZAKOVA O B,et al. Synthesis and anticancer activity of quinopimaric and maleopimaric acids' derivatives[J]. Bioorganic & Medicinal Chemistry,2014,22(22):6481-6489. [4] TRETYAKOVA E V,SMIRNOVA I E,SALIMOVA E V,et al. Synthesis and antiviral activity of maleopimaric and quinopimaric acids' derivatives[J]. Bioorganic & Medicinal Chemistry,2015,23(20):6543-6550. [5] 孙曙光. 左旋海松酸分离方法的改进[J]. 林产化工通讯,1992,26(3):20-21. SUN S G. Levopimaric acid purification optimization[J]. Journal of Chemical Indurstry of Forest Products,1992,26(3):20-21. [6] HUANG X C,HUANG R Z,LIAO Z X,et al. Synthesis and pharmacological evaluation of dehydroabietic acid thiourea derivatives containing bisphosphonate moiety as an inducer of apoptosis[J]. European Journal of Medicinal Chemistry,2016,108:381-391. [7] XING Y H,ZHANG W,SONG J J,et al. Anticancer effects of a novel class rosin-derivatives with different mechanisms[J]. Bioorganic & Medicinal Chemistry Letter,2013,23(13):3868-3872. [8] WASOWSKI C,MARDER M. Central nervous system activities of two diterpenes isolated from Aloysia virgata[J]. Phytomedicine,2011,18(5):393-401. [9] BERDY J. Thoughts and facts about antibiotics:Where we are now and where we are heading[J]. The Journal of Antibiotics,2012,65(8):385-395. [10] SHAN W G,WANG H G,CHEN Y,et al. Synthesis of 3-and 29-substituted celastrol derivatives and structure-activity relationship studies of their cytotoxic activities[J]. Bioorganic & Medicinal Chemistry Letter,2017,27(15):3450-3453. [11] SOMMERWERK S,HELLER L,KERZIG C,et al. Rhodamine B conjugates of triterpenoic acids are cytotoxic mitocans even at nanomolar concentrations[J]. European Journal of Medicinal Chemistry,2017,127:1-9. [12] VILUMS M,ZWEEMER A J,BARMARE F,et al. When structure-affinity relationships meet structure-kinetics relationships:3-((Inden-1-yl)amino)-1-isopropyl-cyclopentane-1-carboxamides as CCR2 antagonists[J]. European Journal of Medicinal Chemistry,2015,93:121-134. [13] JIANG F,WANG H J,BAO Q C,et al. Optimization and biological evaluation of celastrol derivatives as hsp90-cdc37 interaction disruptors with improved druglike properties[J]. Bioorganic & Medicinal Chemistry,2016,24(21):5431-5439. [14] WANG Z M,LI J P,ZENG X D,et al. Synthesis and pharmacological evaluation of novel benzenesulfonamide derivatives as potential anticonvulsant agents[J]. Molecules,2015,20(9):17585-17600. [15] SHI H,FANG L C,TAN C H,et al. Total syntheses of drimane-type sesquiterpenoids enabled by a gold-catalyzed tandem reaction[J]. Journal of the American Chemical Society,2011,133(38):14944-14947. [16] AIHARA Y,CHATANI N. Nickel-catalyzed reaction of C-H bonds in amides with I2:Ortho-iodination via the cleavage of C(sp2)-H bonds and oxidative cyclization to β-lactams via the cleavage of C(sp3)-H bonds[J]. ACS Catalysis,2016,6(7):4323-4329. [17] GOU Q,YANG Y W,LIU Z N,et al. Intermolecular amination of unactivated C(sp3)-H bonds with cyclic alkylamines:Formation of C(sp3)-N bonds through copper/oxygen-mediated C(sp3)-H/N-H activation[J]. Chemistry,2016,22(45):16057-16061. [18] SHANG R,ILIES L,MATSUMOTO A,et al. β-Arylation of carboxamides via iron-catalyzed C(sp3)-H bond activation[J]. Journal of the American Chemical Society,2013,135(16):6030-6032. [19] LUO F X,XU X,WANG D,et al. Cu-Catalyzed alkynylation of unactivated C(sp(3))-X bonds with terminal alkynes through directing strategy[J]. Organic Letters,2016,18(9):2040-2043. [20] YE X H,PETERSEN J L,SHI X D. Nickel-catalyzed directed sulfenylation of sp(2) and sp(3) C-H bonds[J]. Chemical Communications,2015,51(37):7863-7866. [21] WANG Z,NI J Z,KUNINOBU Y,et al. Copper-catalyzed intramolecular C(sp(3))-H and C(sp(2))-H amidation by oxidative cyclization[J]. Angewandte Chemie (International ed. in English),2014,53(13):3496-3499. [22] UM S J,PARK M S,PARK S H,et al. Synthesis of new glycyrrhetinic acid (GA) derivatives and their effects on tyrosinase activity[J]. Bioorganic & Medicinal Chemistry,2003,11(24):5345-5352. [23] STRAGIES R,OSTERKAMP F,ZISCHINSKY G,et al. Design and synthesis of a new class of selective integrin α5β1 antagonists[J]. Journal of Medicinal Chemistry,2007,50(16):3786-3794. [24] RODRIGUEZ A L,TAMRAZI A,COLLINS M L,et al. Design,synthesis,and in vitro biological evaluation of small molecule inhibitors of estrogen receptor alpha coactivator binding[J]. Journal of Medicinal Chemistry,2003,47(3):600-611. [25] MARCHAND P,PUGET A,BAUT G L,et al. Palladium(Ⅱ)-catalyzed heterocyclisation of 8-arylethynyl-1,2,3,4-tetrahydroquinolines:A facile route to 2-aryl-5,6-dihydro-4H-pyrrolo[3,2,1-ij] quinoline derivatives[J]. Tetrahedron,2005,61(16):4035-4041. |